Dataset Information


Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users.

ABSTRACT: OBJECTIVE:We evaluated whether percent time in target range (PTTR), risk of over-anticoagulation [international normalized ratio (INR)>4], and risk of hemorrhage differ by race. As PTTR is a strong predictor of hemorrhage risk, we also determined the influence of PTTR on the risk of hemorrhage by race. PARTICIPANTS AND METHODS:Among 1326 warfarin users, PTTR was calculated as the percentage of interpolated INR values within the target range of 2.0-3.0. PTTR was also categorized as poor (PTTR<60%), good (60?PTTR<70%), or excellent (PTTR?70%) anticoagulation control. Over-anticoagulation was defined as INR more than 4 and major hemorrhages included serious, life-threatening, and fatal bleeding episodes. Logistic regression and survival analyses were carried out to evaluate the association of race with PTTR (?60 vs. <60) and major hemorrhages, respectively. RESULTS:Compared with African Americans, European Americans had higher PTTR (57.6 vs. 49.1%; P<0.0001) and were more likely to attain 60?PTTR<70% (22.9 vs. 13.1%; P<0.001) or PTTR of at least 70% (26.9 vs. 18.2%; P=0.001). Older (>65 years) patients without venous thromboembolism indication and chronic kidney disease were more likely to attain PTTR of at least 60%. After accounting for clinical and genetic factors, and PTTR, African Americans had a higher risk of hemorrhage [hazard ratio (HR)=1.58; 95% confidence interval (CI): 1.04-2.41; P=0.034]. Patients with 60?PTTR<70% (HR=0.62; 95% CI: 0.38-1.02; P=0.058) and PTTR of at least 70% (HR=0.27; 95% CI: 0.15-0.49; P<0.001) had a lower risk of hemorrhage compared with those with PTTR less than 60%. CONCLUSION:Despite the provision of warfarin management through anticoagulation clinics, African Americans achieve a lower overall PTTR and have a significantly higher risk of hemorrhage. Personalized medicine interventions tailored to African American warfarin users need to be developed.


PROVIDER: S-EPMC5657532 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4803610 | BioStudies
2018-01-01 | S-EPMC6014885 | BioStudies
2017-01-01 | S-EPMC5681429 | BioStudies
2009-01-01 | S-EPMC2789741 | BioStudies
2008-01-01 | S-EPMC2757655 | BioStudies
2015-01-01 | S-EPMC4414676 | BioStudies
1000-01-01 | S-EPMC5524023 | BioStudies
2015-01-01 | S-EPMC4508217 | BioStudies
2018-01-01 | S-EPMC6205738 | BioStudies
2014-01-01 | S-EPMC4109410 | BioStudies